Loxapine Dosing
For adults with schizophrenia, start loxapine at 10 mg twice daily (20 mg/day total), increase rapidly over 7-10 days to the usual therapeutic range of 60-100 mg daily in divided doses, with a maximum of 250 mg/day. 1
Standard Adult Dosing
The FDA-approved dosing regimen for loxapine follows a clear escalation pattern 1:
- Initial dose: 10 mg twice daily (20 mg/day total)
- Severely disturbed patients: May start up to 50 mg/day
- Titration: Increase fairly rapidly over first 7-10 days until symptom control achieved
- Therapeutic range: 60-100 mg daily (divided into 2-4 doses)
- Maximum dose: 250 mg/day (not recommended to exceed)
Maintenance Dosing
Once symptoms are controlled, reduce to the lowest effective dose, typically 20-60 mg daily 1. This maintenance approach minimizes long-term side effects while maintaining symptom control.
Special Populations
Elderly Patients
In elderly patients, use doses in the lower range—specifically 10-80 mg daily, which is approximately half the dose used in younger adults 2. The therapeutic dosage range of 10-80 mg daily was established in geropsychiatric patients and showed moderate therapeutic effect with acceptable tolerability 2.
Hepatic Impairment
The provided evidence does not contain specific loxapine dosing adjustments for hepatic impairment. However, the FDA label notes that loxapine accumulates with hepatic impairment 1. Given this pharmacokinetic concern and extrapolating from general principles, start at the lower end of the dosing range (10 mg twice daily) and titrate more cautiously in patients with hepatic dysfunction.
Critical caveat: One case report demonstrated tardive dyskinesia in a patient with Prader-Willi syndrome receiving loxapine 5 mg daily plus paroxetine 40 mg daily—paroxetine significantly reduces loxapine metabolism 3. Monitor closely for drug interactions that inhibit hepatic metabolism.
Low-Dose Strategy
Emerging evidence suggests low-dose loxapine (5-30 mg/day, mean 8.9 mg/day) may be effective and better tolerated in certain populations 3, 4. At doses below 50 mg/day, loxapine demonstrates atypical antipsychotic characteristics with relatively greater 5-HT2A than D2 receptor affinity 4. This low-dose approach showed:
- Equivalent efficacy to standard doses (≥60 mg/day) in some patients 4
- Excellent tolerability with lower extrapyramidal symptoms 3
- Weight neutrality 3
However, this remains investigational for schizophrenia and is not FDA-approved dosing.
Administration Schedule
Administer in divided doses 2-4 times daily 1. The oral route is standard; loxapine is available in capsule form.
Key Safety Considerations
- Chief side effects: Drowsiness, mild extrapyramidal symptoms, slight blood pressure increase 2
- Tardive dyskinesia risk: Monitor with movement disorder scales, especially with concomitant medications that inhibit metabolism 3
- QTc monitoring: Not specifically mentioned for loxapine in provided evidence, but standard practice for antipsychotics
- Avoid supersaturating D2 receptor doses: Higher doses increase adverse effects without additional efficacy 5
Practical Titration Algorithm
- Week 1: Start 10 mg twice daily (or up to 50 mg/day if severely disturbed)
- Days 7-10: Increase to 60-100 mg/day based on response
- Ongoing: Titrate to symptom control, maximum 250 mg/day
- Maintenance: Reduce to 20-60 mg/day once stabilized
For elderly patients: Start 10 mg twice daily, maximum 80 mg/day, slower titration.